Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
02/2011
02/09/2011CN1726914B Slow release tablet of rotundine and production process
02/09/2011CN1547464B Prolonged release bioadhesive therapeutic systems
02/09/2011CN101970458A Novel gamma-secretase inhibitor
02/09/2011CN101970438A Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use
02/09/2011CN101970436A Azaindole compounds for treatment of central nervous system disorders
02/09/2011CN101970433A Gamma secretase modulators
02/09/2011CN101970431A Substituted piperidines as therapeutic compounds
02/09/2011CN101970429A 2-amino-quinoline derivatives useful as inhibitors of beta-secretase (bace)
02/09/2011CN101970428A Carboxamide compounds and their use as calpain inhibitors
02/09/2011CN101970422A Polymorphic form of rotigotine
02/09/2011CN101970408A 4-[2,3-difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine
02/09/2011CN101970005A Breaking immunological tolerance with a genetically encoded unnatural amino acid
02/09/2011CN101969989A Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
02/09/2011CN101969979A Apoaequorin-containing compositions and methods of using same
02/09/2011CN101969965A Fertilized egg isolate and use thereof
02/09/2011CN101969953A Pterin analog for treating bh4 responsive condition
02/09/2011CN101969952A Methods of using and compositions comprising tryptophan hydroxylase inhibitors
02/09/2011CN101969948A Kit, composition, product or medicament for treating cognitive impairment
02/09/2011CN101967186A Encephalitis virus protein and code gene and application thereof
02/09/2011CN101967185A Encephalitis virus protein as well as coding gene and application thereof
02/09/2011CN101967169A 9-(4-beta-D- allopyranosyloxy-phenyl)-decahydroacridine-1,8-diketone as well as preparation method and application thereof
02/09/2011CN101967168A Triterpenoid saponin derivative and preparation method and application thereof
02/09/2011CN101967150A Spiroheterocyclic compounds and their uses as therapeutic agents
02/09/2011CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis
02/09/2011CN101967143A Ligands for G-protein coupled receptors
02/09/2011CN101967117A Substituted pyrrole derivatives and their use as HMG-CO inhibitors
02/09/2011CN101966309A Traditional Chinese medicine for treating diabetes limb necrosis
02/09/2011CN101966302A Chinese medicinal preparation for treating neurodermatitis
02/09/2011CN101966298A Traditional Chinese medicine for treating wind-cold numbness
02/09/2011CN101966292A Sugarless Chinese medicinal oral liquid and preparation method thereof
02/09/2011CN101966290A Medicament for treating neurasthenia and preparation method thereof
02/09/2011CN101966281A Traditional Chinese medicine for treating diabetic stomach paralysis
02/09/2011CN101966266A Chinese medicinal herb health-care pad for postoperative care
02/09/2011CN101966260A Chinese medicinal capsules for treating limb numbness and pain of diabetic concurrent peripheral neuropathy
02/09/2011CN101966253A Tao hong si wu granule and preparation method thereof
02/09/2011CN101966235A Medicament for treating migraine and preparation method thereof
02/09/2011CN101966223A Fingerprint detection method for compound wintercreeper preparation
02/09/2011CN101966210A Folium llicis latifoliae total glycoside and preparation method thereof
02/09/2011CN101966208A Medicament for treating tristimania and preparation method thereof
02/09/2011CN101966199A Application of campanumoea polysaccharide in preparation of medicament and health care food
02/09/2011CN101966194A New application of scutellarin and derivatives thereof
02/09/2011CN101966193A Application of 2,3,5,4-tetrahydroxystilbene-2-O-beta-D-glucoside to preparing medicaments for treating depression
02/09/2011CN101966182A Compound brain protection preparation and preparation method thereof
02/09/2011CN101966181A Oral solid preparation containing candesartan and amlodipine and new application thereof
02/09/2011CN101966172A New purpose of caffeic acid and derivatives thereof
02/09/2011CN101966167A Melatonin soft capsules and preparation method thereof
02/09/2011CN101966151A Trimipramine maleate liposome solid preparation
02/09/2011CN101966146A Medicinal composition solution and preparation method and use thereof
02/09/2011CN101966050A Blood pressure-regulating and sleep-promoting pillow core
02/09/2011CN101965974A Compositions and products containing enantiomeric equol, and methods for their making
02/09/2011CN101606916B Pharmaceutical formulations of modafinil and its uses
02/09/2011CN101518636B Drug for treating long-standing headache and preparation method thereof
02/09/2011CN101518188B Seed reproduction and planting method of Valeriana officinalis L.
02/09/2011CN101485820B Health-care bolus for persons in middle and old age
02/09/2011CN101468154B Chinese medicine preparation for promoting blood circulation, activating collaterals of hemiplegia patient
02/09/2011CN101468153B Analgesia Chinese medicine preparation for treating head wind
02/09/2011CN101444592B Lily qingkailing preparation and preparation method thereof
02/09/2011CN101406631B Medicament for treating hyperkinetic symptom of children
02/09/2011CN101371872B Method for producing hard capsule using Acanthopanax senticosus and schisandra chinensis
02/09/2011CN101322830B Medicament for treating postpartum depression and preparation method thereof
02/09/2011CN101292960B Sustained-release microsphere containing risperidone and preparation method thereof
02/09/2011CN101274063B External plaster for curing facial nerve paralysis and method of preparing the same
02/09/2011CN101272793B Sphingomyelin-containing medicine, food and drink or fodder
02/09/2011CN101181348B Chinese medicine prescription for applying headache and method for preparing the same
02/09/2011CN101181315B New purpose of Yulangsan polysaccharide
02/09/2011CN101076339B Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neurodegenerative disorders
02/09/2011CN101020044B Regulating and controlling effect of thymine DNA glycosylase on signal transducing path
02/08/2011USRE42126 system for delivering oral care substance to oral cavity comprising a removable backing strip having sufficient flexibility to be conformable to oral surface and oral care composition that forms film when applied to backing strip comprising organosiloxane resin, rheology modifier, and oral care substance
02/08/2011US7884204 Phenylalanine derivatives
02/08/2011US7884133 cannabidiol derivatives such as 3-(2,6-dihydroxy-4-pentylphenyl)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid, used as as analgesics, antiinflammatory and antidiarrheal agents
02/08/2011US7884072 produce more stem cells in vivo or in vitro by culture, for transplantation into patient; increase neurogenesis or new olfactory neuron numbers; stroke, neurodegenerative disease of Alzheimer's disease, multiple sclerosis, Huntington's disease, amyotrophic lateral sclerosis, and Parkinson's disease
02/08/2011US7884069 Administering hematopoietic factor; Granulocyte-colony stimulating factor, granulocyte- macrophage CSF (GM-CSF), interleukin-3 (IL-3), and IL-5; neuralogical conditions, ischemia or hypoxia, depression
02/08/2011US7883881 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease
02/08/2011US7883880 DNA polymerase lambda and uses thereof
02/08/2011US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders
02/08/2011US7883714 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
02/08/2011CA2639651C Orally administered peptides to ameliorate atherosclerosis
02/08/2011CA2605899C Triazole derivatives as vasopressin antagonists
02/08/2011CA2446924C 2-iminopyrrolidine derivatives
02/08/2011CA2442319C Carboxylic acid derivative and salt thereof
02/08/2011CA2439117C Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide
02/08/2011CA2401424C Alprazolam inclusion complexes and pharmaceutical compositions thereof
02/08/2011CA2184059C Human trk receptors and neurotrophic factor inhibitors
02/03/2011WO2011014693A2 Bacteriophages expressing amyloid peptides and uses thereof
02/03/2011WO2011014679A1 Method and kit for treating nicotine addiction
02/03/2011WO2011014613A2 Preparation of fipamezole
02/03/2011WO2011014475A2 Treating negative symptoms of schizophrenia associated with defective neuregulin 1
02/03/2011WO2011014098A1 Hydrogenated pyrido[4,3-b]indole derivatives, pharmaceutical composition and methods for the production and use thereof
02/03/2011WO2011014003A2 (+)-3-hydroxymorphinan derivatives as neuroprotectants
02/03/2011WO2011013806A1 Method for production of progenitor schwann cells, and method for proliferation of progenitor schwann cells
02/03/2011WO2011013785A1 Nitrogen-containing spiro-ring compound and medicinal use of same
02/03/2011WO2011013700A1 Carrier peptide fragment and use thereof
02/03/2011WO2011013699A1 Carrier peptide fragment and use thereof
02/03/2011WO2011013646A1 Pharmaceutical product for prevention and treatment of amyotrophic lateral sclerosis
02/03/2011WO2011013470A1 Autoantibody production inhibitor
02/03/2011WO2011012722A1 Prodrugs containing an aromatic amine connected by an amido bond to a linker
02/03/2011WO2011012721A1 Carrier linked pramipexole prodrugs
02/03/2011WO2011012654A1 Hydroxyasenapine compounds, derivatives thereof and pharmaceutical compositions comprising same
02/03/2011WO2011012622A1 Benzoxazinone derivatives for the treatment of glytl mediated disorders
02/03/2011WO2011012534A1 Plk inhibitor salts